Lyndon J. Mitnaul

Regeneron (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

36h-index9.3kcitations77works17.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic Associations and Epidemiology(18), Genomics and Rare Diseases(12), Drug Transport and Resistance Mechanisms(9), Liver Disease Diagnosis and Treatment(6), Peroxisome Proliferator-Activated Receptors(6)

Publications63 total

Genomic Ascertainment of <i>CHEK2</i> -Related Cancer Predisposition
JAMA Network Open·2025Open Access
Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants
Science·2025· 29 citedOpen Access
The impact of common and rare genetic variants on bradyarrhythmia development
Nature Genetics·2025· 13 citedOpen Access
Author response: Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesogenic settings
2024Open Access
Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesogenic settings
eLife·2024· 3 citedOpen Access
Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk
JAMA Cardiology·2024· 41 citedOpen Access
Author Correction: Genotyping, sequencing and analysis of 140,000 adults from Mexico City
Nature·2024· 1 citedOpen Access
Genotyping, sequencing and analysis of 140,000 adults from Mexico City
Nature·2023· 84 citedOpen Access
Plasma proteomic associations with genetics and health in the UK Biobank
Nature·2023· 1.3k citedOpen Access
Author Response: Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesogenic settings
2023Open Access
Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesogenic settings
2023Open Access
Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesogenic settings
eLife·2023Open Access
Biallelic <i>BRCA</i> Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline <i>BRCA1/2</i> Carriers
JCO Precision Oncology·2023· 12 citedOpen Access
Rare coding variants in CHRNB2 reduce the likelihood of smoking
Nature Genetics·2023· 16 citedOpen Access
Genetic Susceptibility to Mood Disorders and Risk of Stroke: A Polygenic Risk Score and Mendelian Randomization Study
Stroke·2023· 5 cited
Assessment of genetic susceptibility to multiple primary cancers through whole-exome sequencing in two large multi-ancestry studies
BMC Medicine·2022· 17 citedOpen Access
Genetic variation of the blood coagulation regulator tissue factor pathway inhibitor and venous thromboembolism among middle‐aged and older adults: A population‐based cohort study
Research and Practice in Thrombosis and Haemostasis·2022· 8 citedOpen Access
Genetic regulation of the human plasma proteome in 54,306 UK Biobank participants
2022· 128 citedOpen Access
Population-scale analysis of common and rare genetic variation associated with hearing loss in adults
Communications Biology·2022· 31 citedOpen Access
High heritability of ascending aortic diameter and trans-ancestry prediction of thoracic aortic disease
Nature Genetics·2022· 57 cited
page 1 of 4Next →

Frequent Co-authors

John D. Overton(35), Jeffrey G. Reid(35), Luca A. Lotta(27), Aris Baras(25), Alan R. Shuldiner(24), Jeffrey Staples(24), Lukas Habegger(23), Suganthi Balasubramanian(22), Xiaodong Bai(22), William Salerno(22), Gonçalo R. Abecasis(22), Aris N. Economides(22), Alicia Hawes(21), Marcus B. Jones(21), Michael Cantor(21), Christina Beechert(21), Caitlin Forsythe(21), Alexander Lopez(21), Manasi Pradhan(21), Kia Manoochehri(21)